Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy

Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy

Prostate cancer-binding peptides- (PCP-) modified polymeric micelles were prepared and used for the treatment of prostate-specific membrane antigen- (PSMA-) expressing prostate cancer in a target-specific manner. Cholesterol-modified glycol chitosan (CHGC) was synthesized. PCP-conjugated CHGC (PCP-C...

Full description

Bibliographic Details
Main Authors:	Jing Xu, Jingmou Yu, Xiao Xu, Liangliang Wang, Yonghua Liu, Lixin Li, Jianguo Zhao, Ming He
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Journal of Nanomaterials
Online Access:	http://dx.doi.org/10.1155/2014/462356

Similar Items

PSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cells.
by: Jian Jin, et al.
Published: (2014-01-01)

PSMA-1-Doxorubicin Conjugates for Targeted Therapy of Prostate Cancer
by: Walker, Natalie
Published: (2019)

Assessment of Palmitoyl and Sulphate Conjugated Glycol Chitosan for Development of Polymeric Micelles
by: Ikram Ullah Khan, et al.
Published: (2013-06-01)

A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway
by: Hailong Zhang, et al.
Published: (2016-05-01)

Recent Progress of Functionalized PSMA in Radionuclide Targeted Therapy for Prostate Cancer
by: REN Ya'nan, et al.
Published: (2020-12-01)

PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
by: Mohamed El Fakiri, et al.
Published: (2021-08-01)

Poly(Ethylene Glycol)–Polylactide Micelles for Cancer Therapy
by: Jixue Wang, et al.
Published: (2018-03-01)

Preparation and Evaluation of Doxorubicin-Loaded Micelles Based on Glycyrrhetinic Acid Modified Gelatin Conjugates for Targeting Hepatocellular Carcinoma
by: Dun Fan, et al.
Published: (2018-01-01)

Co‐delivery of docetaxel and retinoic acid by poly (ethylene glycol)‐retinoic acid conjugates based micelles for synergistic prostate cancer therapy
by: Hang Hu, et al.
Published: (2021-05-01)

Fabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin
by: Zhao J, et al.
Published: (2012-09-01)

PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
by: Wallace Jones, et al.
Published: (2020-05-01)

Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy
by: Zhu Q, et al.
Published: (2011-08-01)

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
by: Magdalena Staniszewska, et al.
Published: (2021-07-01)

Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
by: Asta Juzeniene, et al.
Published: (2021-02-01)

Orbital and brain metastases on 68Ga-PSMA PET/CT in a patient with prostate carcinoma refractory to 177Lu-PSMA and 225Ac-PSMA therapy
by: Ashwin Singh Parihar, et al.
Published: (2021-01-01)

PSMA-targeted imaging of prostate cancer: evolution of a success story
by: Tobias Maurer, et al.
Published: (2017-01-01)

Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives
by: Konstantin Egon Seitzer, et al.
Published: (2021-07-01)

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
by: Fanny Lundmark, et al.
Published: (2020-07-01)

Salvage therapies for PSMA PET-positive nodal recurrent prostate cancer
by: A. Kretschmer, et al.
Published: (2020-07-01)

Editor’s Pick: PSMA-Specific Ligands in Prostate Cancer Diagnosis and Therapy
by: Wei Jin, et al.
Published: (2016-04-01)

Chitosan Oleate Coated Poly Lactic-Glycolic Acid (PLGA) Nanoparticles versus Chitosan Oleate Self-Assembled Polymeric Micelles, Loaded with Resveratrol
by: Dalila Miele, et al.
Published: (2019-09-01)

Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging.
by: Xiaozhou Fan, et al.
Published: (2015-01-01)

Single-lesion Prostate-specific Membrane Antigen Protein Expression (PSMA) and Response to [177Lu]-PSMA-ligand Therapy in Patients with Castration-resistant Prostate Cancer
by: Judith Stangl-Kremser, et al.
Published: (2021-08-01)

Streamlined Schemes for Dosimetry of <sup>177</sup>Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer
by: Jens Kurth, et al.
Published: (2021-08-01)

PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties
by: Piotr Garnuszek, et al.
Published: (2021-03-01)

Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels
by: Sillerud LO
Published: (2016-01-01)

Development of a Novel PSMA - Driven Gene Therapy for the Treatment of Prostate Cancer
by: Page, N. L.
Published: (2010)

Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer
by: Wajahat Khatri, et al.
Published: (2021-04-01)

Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
by: Thomas S. C. Ng, et al.
Published: (2021-07-01)

Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
by: Yu Wang, et al.
Published: (2021-02-01)

Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance
by: Demetrios N. Simopoulos, et al.
Published: (2017-09-01)

<sup>177</sup>Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
by: Yasemin Sanli, et al.
Published: (2021-04-01)

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
by: Eline A.M. Ruigrok, et al.
Published: (2019-10-01)

Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy
by: Jin-Kyu Rhee, et al.
Published: (2014-12-01)

Clinical perspectives of PSMA PET/MRI for prostate cancer
by: Felipe de Galiza Barbosa, et al.
Published: (2018-09-01)

Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis
by: Zhongqing Wu, et al.
Published: (2020-11-01)

Total Tumor Volume on18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with225 Ac-PSMA-I&T
by: Albert, N.L, et al.
Published: (2022)

PSMA-Targeted Mesoporous Silica Nanoparticles for Selective Intracellular Delivery of Docetaxel in Prostate Cancer Cells
by: Eva Rivero-Buceta, et al.
Published: (2019-01-01)

Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin
by: Ashkan Hassankhani Rad, et al.
Published: (2020-03-01)

TNYL peptide functional chitosan-g-stearate conjugate micelles for tumor specific targeting
by: Chen FY, et al.
Published: (2014-09-01)